SG49680A1 - Medicament for the inducement of cognition enhancement - Google Patents

Medicament for the inducement of cognition enhancement

Info

Publication number
SG49680A1
SG49680A1 SG1996004003A SG1996004003A SG49680A1 SG 49680 A1 SG49680 A1 SG 49680A1 SG 1996004003 A SG1996004003 A SG 1996004003A SG 1996004003 A SG1996004003 A SG 1996004003A SG 49680 A1 SG49680 A1 SG 49680A1
Authority
SG
Singapore
Prior art keywords
alkyl
hydrogen
medicament
cognition enhancement
chem
Prior art date
Application number
SG1996004003A
Other languages
English (en)
Inventor
Eric Anthony Muth
John Allen Moyer
Magid Abdel-Megid Abou-Gharbia
George Edward Morris Husbands
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of SG49680A1 publication Critical patent/SG49680A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Traffic Control Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG1996004003A 1994-02-14 1995-01-31 Medicament for the inducement of cognition enhancement SG49680A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19541794A 1994-02-14 1994-02-14

Publications (1)

Publication Number Publication Date
SG49680A1 true SG49680A1 (en) 1998-06-15

Family

ID=22721346

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004003A SG49680A1 (en) 1994-02-14 1995-01-31 Medicament for the inducement of cognition enhancement

Country Status (11)

Country Link
EP (2) EP0667150B1 (es)
JP (1) JPH07252143A (es)
AT (1) ATE229328T1 (es)
CA (1) CA2141774A1 (es)
CY (1) CY2321B1 (es)
DE (1) DE69529109T2 (es)
DK (1) DK0667150T3 (es)
ES (1) ES2185683T3 (es)
LV (1) LV13000B (es)
PT (1) PT667150E (es)
SG (1) SG49680A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) * 1999-04-06 2003-02-10 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
ES2290281T5 (es) * 2001-02-12 2017-09-11 Wyeth Llc Sal de succinato de O-desmetil-venlafaxina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
DE69429895T2 (de) * 1993-06-28 2002-08-29 American Home Products Corp., Madison Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten

Also Published As

Publication number Publication date
CA2141774A1 (en) 1995-08-15
DK0667150T3 (da) 2003-03-31
JPH07252143A (ja) 1995-10-03
ATE229328T1 (de) 2002-12-15
DE69529109T2 (de) 2003-04-30
ES2185683T3 (es) 2003-05-01
CY2321B1 (en) 2003-11-14
EP0667150B1 (en) 2002-12-11
LV13000B (en) 2003-07-20
EP1245228A2 (en) 2002-10-02
EP1245228A3 (en) 2002-10-09
DE69529109D1 (de) 2003-01-23
PT667150E (pt) 2003-02-28
EP0667150A1 (en) 1995-08-16

Similar Documents

Publication Publication Date Title
ES2061670T3 (es) Cicloalcanoles substituidos.
HK1008328A1 (en) Endothelin antagonists
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
HK1025565A1 (en) Intermediates for making camptothecin and camptothecin analogs.
EP0279512A3 (en) Use of certain 5-ht3 receptor antagonists in the treatment of visceral pain
IL139960A0 (en) Macrocylic analogs and methods of their use and preparation
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
PT918776E (pt) Sintese total de acilfulvenos antitumorais
NZ280744A (en) Treatment of hypothalamic amenorrhea in non-depressed female mammals by administering an hydroxycycloalkanephenethylamine derivative
UA81413C2 (en) Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives
PH24309A (en) Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)-ergolines and pharmaceutical formulations thereof
SG49680A1 (en) Medicament for the inducement of cognition enhancement
ES2093246T3 (es) Compuestos de benzazepina terapeuticos.
EG16546A (en) Therapeutic agents
TW275629B (es)
GR3018392T3 (en) N,N',N'-trisubstituted -5-bis-aminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA: cholesterol-acyl transferase.
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases